MiR-155 regulates Th9 differentiation in children with methicillin-resistant Staphylococcus aureus pneumonia by

Keyin Tian1, Weihua Xu2

  • 1Department of Emergency, Anhui Children's Hospital, 39 Wangjiang East Road, Baohe District, Hefei 230051, China; Department of Emergency, Anhui Medical University Affiliated Provincial Children's Hospital, Hefei 230051, China.

Human Immunology
|July 23, 2021
PubMed

Insights

MicroRNA-155 (miR-155) promotes Th9 cell differentiation in children with MRSA pneumonia by targeting SIRT1. This finding reveals a novel mechanism in MRSA infection immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Microbiology

Background:

  • Th9 cells and their primary cytokine IL-9 play a role in immune responses.
  • Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia are significant health concerns.

Purpose of the Study:

  • To investigate the role of miR-155 in Th9 cell differentiation during MRSA pneumonia in children.
  • To elucidate the molecular mechanism by which miR-155 influences Th9 cell differentiation in this context.

Main Methods:

  • Collected bronchoalveolar lavage fluid (BALF) from children with MRSA pneumonia and controls.
  • Utilized RT-PCR, ELISA, and flow cytometry to measure miR-155, IL-9, and Th9 cell numbers.
  • Performed transfection experiments with miR-155 mimic/inhibitor and dual luciferase assays to identify targets.

Main Results:

  • MRSA pneumonia was associated with significantly increased miR-155, IL-9, and Th9 cell numbers in BALF.
  • miR-155 mimic upregulated IL-9 expression and Th9 cell differentiation, while miR-155 inhibitor decreased them.
  • miR-155 was found to target SIRT1, and SIRT1 overexpression reversed miR-155's effects on IL-9 and Th9 cells.

Conclusions:

  • miR-155 plays a crucial role in regulating Th9 cell differentiation in children with MRSA pneumonia.
  • The mechanism involves miR-155 targeting SIRT1, impacting IL-9 production and Th9 cell numbers.